Fine and Custom Chemicals

Pharmaceutical manufacturers often produce drugs using hazardous materials and high temperatures, and their manufacturing processes frequently generate significantly more by-product than the final drug product itself. Sustainable manufacturing historically has not been a priority for the sector, analysts say. This is changing, however, due to: rising raw material prices; increasing pressure to reduce costs; and growing pressure from environmental groups and regulators on pharma and chemical companies to adopt sustainable manufacturing practices. Western pharma...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers